Ali Nahvi
Chief Technology Officer Nava Therapeutics
Seminars
Wednesday 8th April 2026
Developing Scalable & Modular Targeted LNPs for Accelerating LNP-Based Programs from Research to Clinical Approval
12:30 pm
- Mitigating targeted LNP scalability risks by delving into translational hurdles and ensuring manufacturing readiness from early research stages
- Leveraging platform modularity to rapidly advance of targeted LNP programs across diverse therapeutic targets
